Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16908769 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients
Condition: Bleeding
Interventions: Drug: Bivalirudin;   Drug: Unfractionated Heparin

Indicates status has not been verified in more than two years